WRB
W. R. Berkley CorporationEvidence as of 2026-09-03Overview · W. R. Berkley Corporation
W. R. Berkley Corporation, an insurance holding company, operates as a commercial lines writer in the United States and internationally. It operates in two segments, Insurance and Reinsurance & Monoline Excess. The Insurance segment underwrites commercial insurance business, including premises operations, commercial automobile, property, products liability, and general and professional liability lines. It also provid…
Management team
- Ms. Carol Josephine LaPunzina · Senior Vice President of Human ResourcesFind on LinkedIn
- Ms. Karen A. Horvath · Vice President of External Financial CommunicationsFind on LinkedIn
- Mr. Liberatore John Iannarone · Senior VP & General CounselFind on LinkedIn
- Ms. Lucille T. Sgaglione · Executive Vice PresidentFind on LinkedIn
Start your 7-day free trial to see the full management team.
Links open LinkedIn searches, not verified profiles. Team data from our market-data vendor's company profile.
Moneyta sentiment
Where the published evidence leans after the desk debated it — not a rating or a recommendation.
+0.4 on a −2 to +2 scale.
What builds the score
Solid bars are analyst rubric scores; faded bars are computed directly from data. Claims dropped in debate count for nothing; weakened claims count at half weight.
Editor's note
Written after the debate settled — the rest of the page is the evidence behind it.
The surviving evidence paints a constructive picture (+0.4 of a possible +2; confidence high) based on sequential quarterly fundamentals and corporate actions. Revenues rose year‑over‑year from $ 3,547,399,000 in Q1 2025 (fiscal quarter ended 2025-04-28) to $ 3,690,334,000 in Q1 2026 (fiscal quarter ended 2026-04-27) and from $ 3,670,808,000 in Q2 2025 (fiscal quarter ended 2025-07-29) to $ 3,716,119,000 in Q2 2026 (fiscal quarter ended 2026-07-27). Reported net income shows a sequence of $ 417,571,000 in Q1 2025, $ 401,288,000 in Q2 2025, $ 511,032,000 in Q3 2025 (fiscal quarter ended 2025-10-28), $ 515,216,000 in Q1 2026, and $ 452,261,000 in Q2 2026.
Diluted EPS moved from $ 1.04 in Q1 2025 and $ 1.00 in Q2 2025 to $ 1.31 in Q1 2026 and $ 1.15 in Q2 2026, while shares outstanding declined from 380,021,174 on 2025-10-28 to 371,227,529 on 2026-07-27, consistent with $ 302,432,000 of reported share repurchases in Q1 2026. Balance-sheet liabilities rose from $ 33,353,249,000 as of 2025-06-30 to $ 35,834,032,000 as of 2026-06-30, and cash and cash equivalents increased from $ 1,984,529,000 to $ 2,606,530,000 over the same interval. Valuation and liquidity metrics in the packet include a trailing P/FCF of 10.42, trailing TTM P/E of 14.37 (TTM EPS 4.74), implied FCF growth of -6.02% under the model’s assumptions, trailing twelve‑month FCF of $ 2,560,913,000, and enterprise value of $ 22,681,489,275.
How this note was made
every stage ran before the note was writtenAnalyst desk
Mercer, Oakes, Nash, Ellis, Yates, Talbot and Archer. The desk: named AI agents, not people. Each reads one slice of the evidence and nothing else — no outside knowledge, no browsing — so every finding traces to a source you can open.
Reads the XBRL figures companies file with the SEC — revenue, margins, income, debt and share count, quarter by quarter — and reports which way the trend is running.
Revenues in the fiscal quarters compared year-over-year rose from $3,547,399,000 in Q1 2025 (2025-01-01 to 2025-03-31) to $3,690,334,000 in fiscal Q1 2026 (2026-01-01 to 2026-03-31), and from $3,670,808,000 in Q2 2025 (2025-04-01 to 2025-06-30) to $3,716,119,000 in fiscal Q2 2026 (2026-04-01 to 2026-06-30).
XBRL companyfacts · 0000011544-25-000009Net income reported was $417,571,000 in Q1 2025 (2025-01-01 to 2025-03-31), $401,288,000 in Q2 2025 (2025-04-01 to 2025-06-30), $511,032,000 in Q3 2025 (2025-07-01 to 2025-09-30), $515,216,000 in fiscal Q1 2026 (2026-01-01 to 2026-03-31) and $452,261,000 in fiscal Q2 2026 (2026-04-01 to 2026-06-30).
XBRL companyfacts · 0000011544-25-000009Reads the filings themselves, above all the year-over-year diff of Item 1A risk factors: which risks a company added, dropped or quietly reworded since its last annual report.
Nothing in this slice of the evidence rose to a claim — a quiet read, which itself is information.
Which filings the desk reads
The desk reads the annual 10-K in full — its risk factors, and how they changed since last year. Quarterly 10-Qs and event filings (8-Ks, insider Form 4s) are listed for context but not read line by line: the 10-K is where the material risk disclosures live. A brand-new company, or one we have only just begun tracking, may have no annual report on file yet — its risk analysis fills in once that lands.
Reads the signal panel above — momentum, volatility, drawdown, relative strength and beta — and ranks each against the whole research universe rather than judging it in isolation.
No computed signal history for this symbol yet — signals need roughly 70 trading days of price history.
Reads which funds hold the name and at what weight, plus insider Form 4 filings, to show the exposure you may already carry through index funds.
As of 2026-09-02, the iShares Core S&P 500 ETF (IVV) held W. R. Berkley Corporation at 0.03% weight of the fund.
ETF constituents · market dataThe 0.03% weight in IVV indicates a small passive ETF exposure to W. R. Berkley Corporation within that fund as of 2026-09-02.
ETF constituents · market dataReads recent headlines that are genuinely about this company, ignoring rating chatter and market-wide stories. Findings argue in the debate but never move the sentiment score.
Coverage by finance outlets highlights W.R. Berkley’s underwriting discipline as a factor that could help sustain margins amid soft insurance pricing.
News · finance.yahoo.com · 2026-08-28A story about a Berkley Meridian reshuffle describes the company combining Verus Specialty Insurance and Vela Insurance Services and making senior appointments to consolidate specialty capabilities.
News · simplywall.st · 2026-08-27Reads parsed Forms 3/4/5 — who bought or sold, at what size, and whether a 10b5-1 plan was involved. Flags clustered open-market officer buying; treats plan sales as routine and never counts a fund or 10%-holder as an officer.
No insider transactions on file in the trailing 180 days.
Reads the implied-expectations math built from the company's own filings (the growth rate today's price would justify, and the multiples beside it) and argues whether the market's bar looks high or low for this business. Never turns the math into a target.
The model reports an implied free-cash-flow growth rate of -6.02% (the FCF growth rate today's price would justify under the stated discount and terminal assumptions).
Valuation inputs · SEC XBRL + stored EOD closePrice-to-free-cash-flow (P/FCF) is 10.42 based on trailing twelve-month FCF and the quoted price of 68.12.
Valuation inputs · SEC XBRL + stored EOD closeDebate and risk review
A bull and a bear contest the claims and the chair rules on each; the risk review stress-tests what survived.
A bull and a bear argue the analysts' claims across two rounds, then a chair rules on each one. Only what survives feeds the score — the argument is shown, not hidden, so you can judge the reasoning yourself.
The evidence shows sequential year-over-year revenue growth in Q1 and Q2 2026, rising diluted EPS in the comparable 2026 quarters, and sustained net income across recent quarters — signals that operating performance and profitability expanded in the reported periods. Share count has declined alongside meaningful share repurchases, which can amplify per-share metrics; trailing valuation metrics (P/FCF ~10.4 and TTM P/E ~14.4) plus large reported trailing FCF and cash balances indicate material near-term cash generation and liquidity in the filings. News items emphasize underwriting discipline and a strategic consolidation of specialty capabilities, which provide company-specific context for margin resilience rather than a market-wide story. These points jointly support a favorable read of the company’s recent fundamentals and cash generation when weighed against the report showing stronger per-share earnings and active capital return.
Chair's verdict, claim by claim
Fragility · computed, not argued
diversified0.29
19 surviving claims rest on 12 distinct sources; the heaviest analyst carries 32% of them, and 95% of what the desk raised survived the debate.
The evidence base shows moderate breadth but some concentration: 19 surviving claims rely on 12 distinct sources, with the single heaviest analyst responsible for nearly a third of the claims and a very high debate survival rate. That combination means the read is reasonably cohesive but somewhat dependent on a few contributors — surviving claims are durable in the desk process, yet source/analyst concentration reduces how much independent confirmation there is behind each assertion.
Disconfirming evidence · base rates · falsifiers
Context
Outside consensus, and where this name already sits in your own portfolio.
Third-party consensus shown for context. It never enters Moneyta sentiment — when the two diverge, the debate above is where the why lives.
What this was built from
Every figure on this page traces to one of these. The desk reads only what is listed here — no outside knowledge, no browsing — and each card shows who read it and what it contributed to the score.
15 filings· 1 cited
SEC XBRL filings
Quarterly figures as filed with the SEC, read straight from EDGAR's structured data — not retyped or estimated.
Read by Mercer+0.8 to the score
1 holdings record
Fund holdings
Which funds hold this name and at what weight, plus insider Form 4 filings.
Read by Ellis+0.0 to the score
8 headlines· 2 cited
News coverage
Recent headlines about this company, rating chatter excluded and nothing published after the report date.
Read by Yatesnothing survived
1 computation
Valuation inputs
TTM cash-flow figures from the company's own XBRL filings, priced with the stored closing price. Implied growth and multiples only; no fair-value dollar figure reaches the desk, by design.
Read by Archercontext only
1 record· 0 cited
Company profile
Sector, industry and company details.
Read means we pulled and handed it to an analyst; cited means a claim on this page points at it. Reading twelve quarters to state one trend is normal — the gap is shown rather than hidden.
Written by AI, checked against sources
The analysts, the bull–bear debate and the editor's note are AI agents reading only the evidence listed on this page. They can misread a filing or a headline, which is why every claim cites a source you can open and check yourself. The sentiment score is arithmetic over the claims that survived the debate, not a language model's opinion.
Educational analysis of published data. Moneyta does not give investment advice or make recommendations. Past patterns do not indicate future results.
Get this for the tickers you actually hold
Plus the one thing no sample can show: how each name correlates with your portfolio, and what hides inside your funds.
The full terminal on WRB Gold
Who holds it, who's buying, what the Street thinks: live behind the lock, updated as filings land.
Institutional holders
Net institutional flow, Q/Q
Largest holder position
Insider buys, 90 days
Clustered insider value
Street target range
The real figures are for members. Educational analysis, not advice.
Educational analysis of published data. Moneyta does not give investment advice or make recommendations.